Navigation Links
Regis Attends CPhI: The #1 Pharma Sourcing Event in Drug Development
Date:9/30/2015

Regis Technologies will participate in CPhI Worldwide 2015. Regis' Custom Pharma team will be exhibiting in the North American Pavilion at Stand 7C95. This year, CPhI is in Madrid, Spain October 13-15, 2015.

CPhI Worldwide is a global event for the pharmaceutical industry. Covering all aspects of drug development, the event boasts four shows in one, adding ICSE, InnoPack, and P-MEC. This year, 36,000 individuals from over 150 countries will meet in the IFEMA Center in Madrid. The goal is to advance drug development by connecting international suppliers and consumers. With over 2,500 exhibitors, CPhI considers itself the number one sourcing event in the industry.

Regis is a contract manufacturing organization (CMO) for the development and cGMP scale up of small molecule APIs. They partner with pharmaceutical and biotechnology companies to advance their clinical candidates from initial process development, cGMP scale-up through final validation and commercial manufacturing. Regis’ outstanding compliance history, technical and project management teams, and central US location have made it the supplier of choice for emerging and mid-size pharma.

Regis looks forward to reconnecting with international partners and meeting new innovator companies at CPhI. Those interested can register here as Regis' guests for complimentary expo passes.

The Regis Custom Pharma team will be highlighting their newly commissioned Potent Compounds Suite (PCS) to the international oncology market and discussing how Regis can help new high-potency candidates to the clinic. Founded in 1956, Regis is excited to add the new potent compound capabilities to its almost 60 year long resume. Regis’ Director of Business Development, Wayne Nowicki, states, “We see the PCS as an important asset to serve the growing oncology market as more companies look to advance their lead candidates into the clinic.” The PCS provides for small molecule cGMP manufacturing of potent compounds up to about one kilogram per batch. It is now qualified and ready for projects.

To book a meeting at CPhI or for more information on Regis' as a proven provider in drug development, visit their website.

Read the full story at http://www.prweb.com/releases/cphi/regic7C95/prweb12983982.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related biology technology :

1. Regis Shares Expert Advice on Impurities in Drug Development
2. Ceres Announces Pricing of $2.1 Million At-the-Market Registered Direct Offering and Private Placement
3. The National Kidney Registry Partners with Viracor-IBT Laboratories to Accelerate Living Donor Transplantation
4. Paradigm and TME Research To Launch Precision Medicine Breast Cancer Registry
5. Ralco Registers Forage Enhancement Products in China
6. Americord Registry Considering Strategic Options
7. ImmunoCellular Therapeutics Establishes Agreement with Novella Clinical to Conduct ICT-107 Phase 3 Registration Trial in Glioblastoma
8. Americord Registry Announces Andrew Horne as Advisory Board Member
9. ProNAi Therapeutics Files Registration Statement for Proposed Initial Public Offering
10. Regis Technologies Offers Chiral Chromatography Service
11. Celsion Corporation Announces $8 Million At-The-Market Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/24/2019)... ... September 24, 2019 , ... Drug resistance has been declared as ... Organization, with MRSA becoming one of the most serious concerns. Hong Kong cannot be ... of community-associated MRSA (CA-MRSA), or a seven-fold of the figure in 2007 – the ...
(Date:9/24/2019)... ... September 24, 2019 , ... In the past three ... led by faculty at South Dakota School of Mines & Technology that ... that attach to surfaces to form a slimy and yet strong layer which is ...
(Date:9/17/2019)... ... September 17, 2019 , ... Geneticure, ... chronic diseases, announces today that the U.S. Patent and Trademark Office (USPTO) and ... to rank drug class recommendations for hypertension treatment. , The patent applies ...
(Date:9/17/2019)... ... September 16, 2019 , ... MyBioGate Global Healthcare Innovation ... Biotech Week Boston, a forum organized by MyBioGate, Inc. and CUBIO Innovation Center ... a careful process of evaluation, twelve companies out of over 200 applications were ...
Breaking Biology Technology:
(Date:9/30/2019)... , ... September 30, 2019 , ... ... focused on increasing the capacity of life science organizations to accelerate innovation and ... Francisco, CA on October 4th. , What: Just 30 days to 21 CFR ...
(Date:9/25/2019)... ... 2019 , ... Modality Solutions, a biopharmaceutical cold ... Magazine’s annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing ... this growth, the Houston-based firm also ranked No. 47 in its industry category ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... for accelerated drug development, announced today that it has raised $2.8M from leading ... Fund and also includes AME Cloud Ventures, Boom Capital, Madrona Venture Group, Sahsen ...
Breaking Biology News(10 mins):